Description
Mubritinib is an EGFR2 (HER2) inhibitor that underwent clinical trials, showing some promise as an anticancer chemotherapeutic in the treatment of bladder, kidney, and prostate cancer, but was not pursued further.
Product Unit Size | Cost | Quantity | Stock |
---|
Mubritinib is an EGFR2 (HER2) inhibitor that underwent clinical trials, showing some promise as an anticancer chemotherapeutic in the treatment of bladder, kidney, and prostate cancer, but was not pursued further.
Cas No. | 366017-09-6 |
---|---|
Purity | ≥99% |
Formula | C25H23F3N4O2 |
Formula Wt. | 468.47 |
Chemical Name | 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole |
IUPAC Name | 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4- (trifluoromethyl)phenyl]ethenyl]-1,3-oxazole |
Synonym | TAK-165 |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Nagasawa J, Mizokami A, Koshida K, et al. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo. Int J Urol. 2006 May;13(5):587-92. PMID: 16771730.
Polyphenol found in olive oil, antioxidant.
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...
Quaternary base alkaloid found in Phellodendron...
CRM1/XPO1 inhibitor.
Bosutinib isomer; Src and Abl inhibitor.
ITC found in cruciferous vegetables; AhR antago...
Acyl transfer catalyst, involved in peptide syn...
Nitrofuran derivative.
Azoxy compound
Negative control for PKC activation.
Endogenous component of sphingolipids; PKC inhi...
Endogenous precursor to all steroid hormones; T...
ACE inhibitor.
Synthetic peptide, vasopressin derivative; V2 a...
NSAID; COX-2 inhibitor.
HEXIM1 activator.
Polyether neurotoxin found in Karenia brevis; N...
Triterpene saponin found in Panax.
Cortisol derivative; glucocorticoid agonist.
Endogenous peptide hormone, involved in intesti...